Immunohistochemical profiling of ALK fusion gene-positive adenocarcinomas of the lung (Q43983107)

28 November 2017

title

Immunohistochemical profiling of ALK fusion gene-positive adenocarcinomas of the lung (English)

1 reference

28 November 2017

1 reference

1 reference

Yasuhiro Sakai

1

1 reference

28 November 2017

Tokiko Nakai

2

1 reference

28 November 2017

Chiho Ohbayashi

3

1 reference

28 November 2017

Naoko Imagawa

4

1 reference

28 November 2017

Emmy Yanagita

5

1 reference

28 November 2017

Rumiko Satake

6

1 reference

28 November 2017

Atsushi Nitta

7

1 reference

28 November 2017

Kazuyoshi Kajimoto

8

1 reference

28 November 2017

Toshiko Sakuma

9

1 reference

28 November 2017

Tomoo Itoh

10

1 reference

28 November 2017

publication date

20 June 2013

1 reference

International Journal of Surgical Pathology

28 November 2017

published in

1 reference

28 November 2017

volume

21

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

476-482

1 reference

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diag

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Utility of 10 Immunohistochemical Markers Including Novel Markers (Desmocollin-3, Glypican 3, S100A2, S100A7, and Sox-2) for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Keratin expression in human tissues and neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

The Diagnostic Value of Cytokeratin 5/6, 14, 17, and 18 Expression in Human Non-Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

A 6-Antibody Panel for the Classification of Lung Adenocarcinoma Versus Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Comprehensive histologic analysis of ALK-rearranged lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

ALK translocation in non-small cell lung cancer with adenocarcinoma and squamous cell carcinoma markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

A novel KIF5B‐ALK variant in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/1066896913489345

21 January 2018

Identifiers

DOI

10.1177/1066896913489345

1 reference

28 November 2017

1 reference